Hope on the Horizon: Trials, Treatments and Therapies for DMD, DM1 & MG
Muscular Dystrophy Canada in partnership with the Neuromuscular Disease Network for Canada’s Clinical Trial Network is excited to host three Hope on the Horizon events!
These webinars are geared towards family members and people living with NMDs.
Join us to learn more about the treatment and clinical trial landscape for Duchenne Muscular Dystrophy, Myotonic Dystrophy Type 1 and Myasthenia Gravis from key experts in the field!
Learn More and Register:
- Nov 26, 2025: Duchenne Muscular Dystrophy
- Nov 27, 2025: Myotonic Dystrophy Type 1
- Nov 28, 2025: Myasthenia Gravis
Post-Event Update
Click to watch the webinars on MDC’s YouTube Channel.
Read next...
2026 NMD4C Application & Nomination Deadlines
As we start the new year, three important NMD4C opportunities are approaching their deadlines. Members are invited to nominate a researcher or publication for the Annual NMD4C Awards, apply to join the Basic Science Trainee Committee (BSTC), and apply to attend the 2026 NMD4C Basic Research Summer School, taking place June 8–10 under the leadership of Dr. Mireille Khacho. Registration for the summer school is free, with travel and accommodations covered for non‑local trainees.
Announcing the 2026 Neuromuscular Postdoctoral Fellowship Funding Recipients!
Together with Muscular Dystrophy Canada (MDC), we’re excited to share that the 2026 Neuromuscular Postdoctoral Research Fellows have been awarded! This year’s competition provided salary support for two exceptional early‑career scientists to pursue postdoctoral research in Canadian laboratories dedicated to advancing neuromuscular research. Successful applicants will receive $40,000 in funding over a one-year period.
